Ad is loading...
ABVX
Price
$9.50
Change
-$0.46 (-4.62%)
Updated
Nov 15 closing price
MRVI
Price
$4.42
Change
-$0.78 (-15.00%)
Updated
Nov 15 closing price
94 days until earnings call
Ad is loading...

ABVX vs MRVI

Header iconABVX vs MRVI Comparison
Open Charts ABVX vs MRVIBanner chart's image
Abivax SA
Price$9.50
Change-$0.46 (-4.62%)
Volume$91.46K
CapitalizationN/A
Maravai LifeSciences Holdings
Price$4.42
Change-$0.78 (-15.00%)
Volume$4.08M
CapitalizationN/A
ABVX vs MRVI Comparison Chart
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABVX vs. MRVI commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Sell and MRVI is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ABVX: $9.50 vs. MRVI: $4.42)
Brand notoriety: ABVX and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 73% vs. MRVI: 223%
Market capitalization -- ABVX: $624.11M vs. MRVI: $626.95M
ABVX [@Biotechnology] is valued at $624.11M. MRVI’s [@Biotechnology] market capitalization is $626.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 5 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 5 bullish, 3 bearish.
  • MRVI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than MRVI.

Price Growth

ABVX (@Biotechnology) experienced а -9.26% price change this week, while MRVI (@Biotechnology) price change was -12.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ABVX is expected to report earnings on Nov 07, 2024.

MRVI is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($627M) and ABVX($624M) have the same market capitalization . ABVX YTD gains are higher at: -11.215 vs. MRVI (-32.519).
ABVXMRVIABVX / MRVI
Capitalization624M627M100%
EBITDAN/A701M-
Gain YTD-11.215-32.51934%
P/E RatioN/AN/A-
RevenueN/A279M-
Total CashN/A573M-
Total DebtN/A562M-
TECHNICAL ANALYSIS
Technical Analysis
ABVXMRVI
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYPCX18.570.02
+0.11%
Delaware Ivy Systematic Em Mkts Eq R
WPGTX21.15-0.15
-0.70%
WPG Partners Small Cap Value Div Fund
VSSVX13.12-0.14
-1.06%
VALIC Company I Small Cap Special Val
PSPJX28.54-0.38
-1.31%
Principal Large Cap S&P 500 Index J
HNSGX15.09-0.28
-1.82%
Harbor Small Cap Growth Retirement

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with INZY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
-4.62%
INZY - ABVX
33%
Loosely correlated
-8.89%
RARE - ABVX
31%
Poorly correlated
-6.07%
TNYA - ABVX
29%
Poorly correlated
-2.48%
MRVI - ABVX
28%
Poorly correlated
-15.00%
OCEA - ABVX
28%
Poorly correlated
-0.83%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with VIR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
-15.00%
VIR - MRVI
35%
Loosely correlated
-7.29%
OCEA - MRVI
35%
Loosely correlated
-0.83%
AXON - MRVI
34%
Loosely correlated
-0.86%
VCYT - MRVI
33%
Loosely correlated
-2.97%
CYTK - MRVI
30%
Poorly correlated
-8.19%
More